Modified Delphi panel consensus recommendations for management of severe aplastic anemia

Area of Science:

• Hematology
• Oncology
• Clinical Medicine

Background:

• Severe aplastic anemia (SAA) is a rare hematologic disorder lacking a definitive management algorithm.
• Current treatment strategies for SAA require clear guidelines to optimize patient outcomes.

Purpose of the Study:

• To develop evidence-based clinical recommendations for the management of severe aplastic anemia (SAA) across all age groups.
• To provide guidance on initial and subsequent therapy, including distinguishing between transplant and medical interventions.

Main Methods:

• A modified Delphi panel method was employed, involving 11 experts in adult and pediatric aplastic anemia.
• Over 600 patient care scenarios were evaluated to establish consensus-based recommendations.

Main Results:

• Recommendations were formulated for ruling out inherited bone marrow failure syndromes.
• Guidelines address supportive care before and during first-line therapy for acquired SAA.
• Consensus was reached on first-line and second-line treatment strategies, including the optimal timing for stem cell transplant versus medical therapy.

Conclusions:

• The expert panel's recommendations offer guidance for experienced clinicians treating SAA patients.
• Validation of these consensus guidelines through clinical data is recommended to improve SAA patient outcomes.
• These recommendations aim to standardize and enhance the care of individuals diagnosed with severe aplastic anemia.